the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean

Market Research Report

Market Dynamics: Bone Substitutes and Growth Factors- Can BMPs Become the New Gold Standard?

Published by Datamonitor Contact us : +1-860-674-8796
Published 2002/11 Content info  
Product code DC12225
Price From  US $ 7600 Order/Price list
US $ 7600 PDF by E-mail (Single User License)
US $ 19000 PDF by E-mail (Global License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

INTRODUCTION

The introduction of bone morphogenic proteins (BMPs) can turn the bone graft market on its head. Though overpriced, they have the potential to eclipse all other products including synthetic substitutes, allografts, demineralized bone matrices (DBMs), and machined bone. What does the future hold for the bone graft markets in the US, France, Germany, Italy, Spain, the UK and Japan?

SCOPE OF THIS REPORT

  • Key data and detailed analysis of the 7 leading country markets: the US, Japan, Germany, France, Italy, Spain, and the UK

  • Analyses and transcripts of interviews with 9 top global thought leaders including discoverers of BMPs

  • Forecasts for the bone substitutes and growth factor market to 2006, broken down by country and product segment

REPORT HIGHLIGHT

  • Clinical trial data has shown BMPs to be as efficacious as autograft, the gold standard in bone grafting, in certain indications. However, there is still not much data available conclusively proving their efficacy and their price is extraordinarily high.
  • DBM use in Europe is small. This may be due to lack of availability in this region. European thought leaders express positive views for their potential but have been unable to realize it due to marketing barriers. Europe represents a huge untapped market for DBMs.
  • AGF systems are being marketed as cheap but effective alternatives to BMPs. Although some surgeons believe in them, few feel these systems have as great a potential as BMPs. The prevailing sentiment is that they are promising, but they haven't yet found their ideal indication.

KEY REASONS TO BUY THIS REPORT

  • Learn which bone graft substitute segments are growing fastest, which have the best long-term potential, and which should be avoided

  • Benchmark your company's R&D status by gaining knowledge of bone substitute and growth factor products on the market and in clinical trials

  • Profit from recommendations from those who will be the final decision-makers in the future of bone grafting

  • Assess the threat of BMPs to the bone graft substitute market in the short and long term
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.